Legal cannabis could become a reality in Paraguay, at least for medical use, in the coming months, as the government is studying a bill that deals with the regulation and decriminalization of cannabis. According to the draft, anyone in possession of cannabis for medical use, prescribed by a certified doctor, will be exempt for any penalty related to this plant.
Cannabis is advancing in Latin America at a sprinter pace, and the experts in the field have not yet done anything. Of all the gardens on the youngest continent on the planet, there is one that has been more active than all, although in hiding.
This is Paraguay, a true regional mecca for cannabis cultivation and a historic provider for users of the Southern Cone. Also, one of the main responsible for the damage to public health that the cannabis industry had on the continent. And thanks to the offer of pressing.
The product originated in Paraguay is a compress of flowers, branches, leaves and soil preserved with toxic chemicals for health. Although profitable in a context of illegality. Luckily, the years passed and America refined its consumption (at least in terms of cannabis).
Now, Paraguay is finally discussing a decriminalization of its most beautiful flower.
“The Chamber of Deputies is studying in its ordinary session the bill that decriminalizes the self-cultivation of cannabis for medicinal use,” the official channels reported.
If you want to know more about cannabis, how Paraguay is studying the best way to legalize cannabis for medical use, and to find out the latest cannabis news, download the Hemp.im mobile application.
Cannabis possession will still be punishable if exceeded the limit established
From a pessimistic point of view, the Commission to Combat Drug Trafficking, chaired by Deputy Tito Ibarrola (PH) would give a negative assessment of the bill. Its members advise ratifying themselves in the initial rejection and to archive the project they will need 53 votes.
The norm indicates that whoever has in his possession substances referred to by law, which the doctor has prescribed, or whoever has them for his exclusive personal use, will be exempt from penalty.
But if the amount is greater than prescribed or necessary for personal use, the person in case will be punished with a penitentiary of two to four years and confiscation. The possession of cannabis or its derivatives for exclusively medicinal use will not be punishable.
Of course, in cases in which the holder carries a medical certificate endorsed by the Ministry of Public Health and Social Welfare. He must indicate that he suffers from ailments treatable with medical cannabis, says the rule that, unfortunately, could not be treated with other treatments.
The bill has strong opposition in the senate
The Anti-Drug Commission of the Paraguayan Parliament is the main opponent of what was called the “Mamá Cultiva” law. This civil association is the pioneer in promoting the self-cultivation of cannabis for medicinal purposes.
In a virtual meeting weeks ago, the Commission decided to reject the bill that seeks to modify various provisions of the anti-drug legislation. The purpose of the initiative was to authorize the medicinal self-cultivation of cannabis to treat certain pathologies, the Chamber of Deputies reported in a press report.
The deputies adopted this position taking into account the recommendations of the Ministry of Public Health, the Prosecutor’s Office, the National Anti-Drug Secretariat (Senad) and the medical unions.
“Basically what these institutions have been aspects related to the National Constitution, as well as international treaties and current laws that already provide for the free distribution of the production and distribution of cannabis for medicinal purposes,” said the president of the Antinarcotics of the Lower House, the deputy for Central Tito Ibarrola (PPH).
The opinion must be submitted to the plenary for consideration when the deputies study the bill in question.
The proposal is promoted by the Mamá Cultiva Paraguay Organization and was presented by Senator Víctor Ríos (PLRA). It intended to allow self-cultivation exclusively to patients who have a prescription approved and registered with the Ministry of Health.
Deputy Ibarrola recalled that the Commission has already urged the Executive Power, through a statement, to immediately provide medicine to people who need it and that it is contemplated in the current law but is not yet fulfilled.
This latest legislation states that only pharmaceutical companies can be authorized to import raw material or produce it locally to prepare cannabis-based medicines.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in La Marihuana, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.